Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset


Por: Hong, SJ, Prokopenko, D, Dobricic, V, Kilpert, F, Bos, I, Vos, SJB, Tijms, BM, Andreasson, U, Blennow, K, Vandenberghe, R, Cleynen, I, Gabel, S, Schaeverbeke, J, Scheltens, P, Teunissen, CE, Niemantsverdriet, E, Engelborghs, S, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Molinuevo, JL, Rami, L, Kettunen, P, Wallin, A, Lleo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Dobson, RJB, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, ten Kate, M, Barkhof, F, Zetterberg, H, Lovestone, S, Streffer, J, Wittig, M, Franke, A, Tanzi, RE, Visser, PJ, Bertram, L, Alzheimers Dis Neuroimaging Initia

Publicada: 22 dic 2020 Ahead of Print: 22 nov 2020
Resumen:
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. Elucidating the genetic architecture of additional AD-related phenotypic traits, ideally those linked to the underlying disease process, holds great promise in gaining deeper insights into the genetic basis of AD and in developing better clinical prediction models. To this end, we generated genome-wide single-nucleotide polymorphism (SNP) genotyping data in 931 participants of the European Medical Information Framework Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) sample to search for novel genetic determinants of AD biomarker variability. Specifically, we performed genome-wide association study (GWAS) analyses on 16 traits, including 14 measures derived from quantifications of five separate amyloid-beta (A beta) and tau-protein species in the cerebrospinal fluid (CSF). In addition to confirming the well-established effects of apolipoprotein E (APOE) on diagnostic outcome and phenotypes related to A beta 42, we detected novel potential signals in the zinc finger homeobox 3 (ZFHX3) for CSF-A beta 38 and CSF-A beta 40 levels, and confirmed the previously described sex-specific association between SNPs in geminin coiled-coil domain containing (GMNC) and CSF-tau. Utilizing the results from independent case-control AD GWAS to construct polygenic risk scores (PRS) revealed that AD risk variants only explain a small fraction of CSF biomarker variability. In conclusion, our study represents a detailed first account of GWAS analyses on CSF-A beta and -tau-related traits in the EMIF-AD MBD dataset. In subsequent work, we will utilize the genomics data generated here in GWAS of other AD-relevant clinical outcomes ascertained in this unique dataset.

Filiaciones:
Hong, SJ:
 Univ Lubeck, Inst Neurogenet, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Lubeck, Inst Neurogenet & Cardiogenet Univ, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Prokopenko, D:
 Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Unit, Boston, MA 02114 USA

 Massachusetts Gen Hosp, Dept Neurol, McCance Ctr Brain Hlth, Boston, MA 02114 USA

Dobricic, V:
 Univ Lubeck, Inst Neurogenet, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Lubeck, Inst Neurogenet & Cardiogenet Univ, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Kilpert, F:
 Univ Lubeck, Inst Neurogenet, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Lubeck, Inst Neurogenet & Cardiogenet Univ, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

Bos, I:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

 Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam UMC,Amsterdam Neurosci, Amsterdam, Netherlands

Vos, SJB:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands

Tijms, BM:
 Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam UMC,Amsterdam Neurosci, Amsterdam, Netherlands

Andreasson, U:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

Blennow, K:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

Vandenberghe, R:
 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

 Univ Hosp Leuven, Neurol Serv, Leuven, Belgium

Cleynen, I:
 Katholieke Univ Leuven, Dept Human Genet, Lab Complex Genet, Leuven, Belgium

Gabel, S:
 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

Schaeverbeke, J:
 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

Scheltens, P:
 Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam UMC,Amsterdam Neurosci, Amsterdam, Netherlands

Teunissen, CE:
 Vrije Univ, Amsterdam Univ Med Ctr, Dept Clin Chem, Neurochem Lab,Amsterdam Neurosci, Amsterdam, Netherlands

Niemantsverdriet, E:
 Univ Antwerp, Inst Born Bunge, Dept Biomed Sci, Antwerp, Belgium

Engelborghs, S:
 Univ Antwerp, Inst Born Bunge, Dept Biomed Sci, Antwerp, Belgium

 UZ Brussel, Dept Neurol, Brussels, Belgium

 UZ Brussel, Ctr Neurosci, Brussels, Belgium

 Vrije Univ Brussel VUB, Brussels, Belgium

Frisoni, G:
 Univ Geneva, Geneva, Switzerland

 IRCCS Ist Ctr San Giovanni di Dio Fatebenefratell, Brescia, Italy

Blin, O:
 AIX Marseille Univ, AP HM, INS, Marseille, France

Richardson, JC:
 GlaxoSmithKline R&D, Neurosci Therapeut Area, Stevenage, Herts, England

Bordet, R:
 Univ Lille, CHU Lille, INSERM, Lille, France

Molinuevo, JL:
 Hosp Clin & Univ, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain

Rami, L:
 Hosp Clin & Univ, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain

Kettunen, P:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Univ Oxford, Dept Neuropathol, Nuffield Dept Clin Neurosci, Oxford, England

Wallin, A:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

Lleo, A:
 Hosp Santa Creu & Sant Pau, Neurol Dept, Memory Unit, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain

Sala, I:
 Hosp Santa Creu & Sant Pau, Neurol Dept, Memory Unit, Barcelona, Spain

 Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain

Popp, J:
 Geneva Univ Hosp, Dept Mental Hlth & Psychiat, Geriatr Psychiat, Geneva, Switzerland

 Univ Hosp Lausanne, Dept Psychiat, Lausanne, Switzerland

Peyratout, G:
 Univ Hosp Lausanne, Dept Psychiat, Lausanne, Switzerland

Martinez-Lage, P:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, Dept Neurol, San Sebastian, Spain

Tainta, M:
 CITA Alzheimer Fdn, Ctr Res & Adv Therapies, Dept Neurol, San Sebastian, Spain

Dobson, RJB:
 Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England

 Kings Coll London, NIHR Maudsley Biomed Res Ctr BRC, South London & Maudsley NHS Fdn Trust SLaM, NIHR BioResource Ctr Maudsley, London, England

 Kings Coll London, Inst Psychiat Psychol & Neurosci IoPPN, London, England

 UCL, Hlth Data Res UK London, 222 Euston Rd, London, England

 UCL, Inst Hlth Informat, 222 Euston Rd, London, England

 UCL, Univ Coll London Hosp Biomed Res Ctr, Natl Inst Hlth Res, 222 Euston Rd, London, England

Legido-Quigley, C:
 Steno Diabet Ctr, Copenhagen, Denmark

 Kings Coll London, Inst Pharmaceut Sci, London, England

Sleegers, K:
 VIB, Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium

 Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium

Van Broeckhoven, C:
 VIB, Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium

 Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium

ten Kate, M:
 Amsterdam Univ Med Ctr, Alzheimer Ctr, Amsterdam Neurosci, Amsterdam, Netherlands

 Amsterdam Univ Med Ctr, Dept Neurol, Amsterdam Neurosci, Amsterdam, Netherlands

 Amsterdam Univ Med Ctr, Dept Radiol & Nucl Med, Amsterdam Neurosci, Amsterdam, Netherlands

Barkhof, F:
 UCL, Inst Neurol, London, England

Zetterberg, H:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

 UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England

 UCL, UK Dementia Res Inst, London, England

Lovestone, S:
 Univ Oxford, Dept Psychiat, Oxford, England

Streffer, J:
 Univ Antwerp, Reference Ctr Biol Markers Dementia BIODEM, Inst Born Bunge, Antwerp, Belgium

 UCB Biopharma SPRL, Translat Med Neurosci, Braine Lalleud, Belgium

Wittig, M:
 Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany

Franke, A:
 Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany

Tanzi, RE:
 Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Unit, Boston, MA 02114 USA

 Massachusetts Gen Hosp, Dept Neurol, McCance Ctr Brain Hlth, Boston, MA 02114 USA

Visser, PJ:
 Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam UMC,Amsterdam Neurosci, Amsterdam, Netherlands

Bertram, L:
 Univ Lubeck, Inst Neurogenet, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Lubeck, Inst Neurogenet & Cardiogenet Univ, Lubeck Interdisciplinary Platform Genome Analyt L, Lubeck, Germany

 Univ Oslo, Dept Psychol, Oslo, Norway
ISSN: 21583188





Translational Psychiatry
Editorial
SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 10 Número: 1
Páginas: 403-403
WOS Id: 000591602800001
ID de PubMed: 33223526
imagen Gold, Green Published

MÉTRICAS